BPI 2026 has ended. This guide stays up as the record of who was there. Next: BPI 2027, Sep 20–23, 2027 in Boston

GenSight Biologics at BPI 2026

Sep 22–25, 2026 Boston, MA ~3k attendees Website

GenSight Biologics takes part in 2 sessions at BPI 2026 in Boston. Its sessions centre on gene therapy approval and on cell and gene therapy roundtables in the exhibit hall. One covers strategies for a streamlined path to BLA success for a gene therapy.

OrganizationBPI 2026 Attendance
GenSight Biologics
Paris, France
Biotech
Developer of gene therapies for retinal neurodegenerative diseases such as Leber hereditary optic neuropathy.
Talk
Wed Sep 23
5:00pm–5:45pm
CGT Exhibit Hall Roundtable Discussions
CGT Community Hub (Exhibit Hall) · with Aspen Neuroscience
Panel
Fri Sep 25
9:00am–10:00am
Keynote Panel Discussion: Navigating BLA Success - Strategies for Streamlined Gene Therapy Approval Success
Gene Therapy Manufacturing & Analytics · with University College Cork, Ultragenyx, Rocket Pharmaceuticals +1 more

Explore the full BPI 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full BPI 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at GenSight Biologics

Tell us what you sell and we’ll find the people at GenSight Biologics most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the BioProcess International Conference & Exhibition or its organizers. Submit a correction